Search Results 761-770 of 19742 for Hepatitis+C

1. A Study to Evaluate Pembrolizumab, Ixazomib Citrate, and Dexamethasone to Treat Participants with Relapsed Multiple Myeloma - Mayo Clinic

   Has known active hepatitis B (e.g., hepatitis B surface antigen [HBsAg] reactive) or hepatitis C (e.g., hepatitis C virus [HCV] ribonucleic acid [RNA] [ ...

2. A Study of Niraparib Combined with Pembrolizumab (MK-3475) in Patients who have Triple-Negative Breast Cancer or Ovarian Cancer - Mayo Clinic

   Known active hepatitis B or hepatitis C; Active autoimmune disease that has required systemic treatment in the past 2 years (ie, with use of disease ...

3. A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma - Mayo Clinic

   Patients with history or presence of human immunodeficiency virus and/or potentially active hepatitis B virus/hepatitis C virus infection. Note: Other ...

4. A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas - Mayo Clinic

   ... Hepatitis B (HBsAg reactive), or Hepatitis C (HCV RNA (qualitative) is detected); patients with negative Hepatitis C antibody testing may not need RNA testing.

5. Vancomycin for Primary Sclerosing Cholangitis - Mayo Clinic

   Hepatitis B infection ii. Hepatitis C infection (antibody positive); patients with a history of hepatitis C infection will be eligible for this study if ...

6. A Dose Ranging Study Evaluating Efficacy And Safety Of NI-03 - Mayo Clinic

   History or presence of hepatitis B (surface antigen positivity), active hepatitis C or human immunodeficiency virus (HIV) antibody; Active infection within ...

7. Phase I Study of LB-100 With Docetaxel in Solid Tumors - Mayo Clinic

   ... C or nitrosoureas, for which patients must be 6 weeks from prior treatment. ... Patients with known active human immunodeficiency virus (HIV), hepatitis B virus ( ...

8. AMG 181 in Subjects with Moderate to Severe Crohn's Disease - Mayo Clinic

   Known to have tested positive for hepatitis B virus surface antigen, hepatitis C virus antibody, or HIV; Any underlying condition that predisposes subject to ...

9. Doxorubicin Hydrochloride, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma - Mayo Clinic

   ... hepatitis C ≤1 year prior to registration. Adequate bone marrow function ... Known active Hepatitis B (e.g., HBsAg reactive) or Hepatitis C (e.g., HCV RNA [ ...

10. Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer - Mayo Clinic

    ... hepatitis B core antigen] antibody test) are eligible;; Patients positive for hepatitis C virus (HCV) antibody are eligible only if polymerase chain reaction ...